We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.14%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3B
AUM Growth
-$140M
Cap. Flow
-$317M
Cap. Flow %
-10.57%
Top 10 Hldgs %
28.72%
Holding
6,693
New
497
Increased
2,742
Reduced
2,422
Closed
658

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$73.5M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$65.4M
3
MSFT icon
Microsoft
MSFT
+$34M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$12.5M
5
CMCSA icon
Comcast
CMCSA
+$11.4M

Sector Composition

Rank Sector Weight
1 Technology 18.87%
2 Financials 7.81%
3 Consumer Discretionary 7.79%
4 Industrials 7.37%
5 Healthcare 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLMB icon
1851
Climb Global Solutions
CLMB
$519M
$133K ﹤0.01%
11,108
+9,316
+520% +$113K
SUPN icon
1852
Supernus Pharmaceuticals
SUPN
$2.77B
$133K ﹤0.01%
4,411
+3,084
+232% +$108K
MIR icon
1853
Mirion Technologies
MIR
$3.91B
$132K ﹤0.01%
15,671
+12,724
+432% +$103K
TFII icon
1854
TFI International
TFII
$11.5B
$132K ﹤0.01%
1,162
-197
-14% -$21.6K
TBT icon
1855
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$305M
$132K ﹤0.01%
4,500
-19,326
-81% -$564K
CPE
1856
DELISTED
Callon Petroleum Company
CPE
$132K ﹤0.01%
3,769
-1,120
-23% -$37.5K
KDNY
1857
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$132K ﹤0.01%
3,439
-1,590
-32% -$40.8K
MMSI icon
1858
Merit Medical Systems
MMSI
$5.32B
$132K ﹤0.01%
1,579
+113
+8% +$9.19K
VIPS icon
1859
Vipshop
VIPS
$7.53B
$132K ﹤0.01%
8,000
+7,800
+3,900% +$122K
JOUT icon
1860
Johnson Outdoors
JOUT
$505M
$132K ﹤0.01%
2,146
+1,975
+1,155% +$118K
BANR icon
1861
Banner Corp
BANR
$2.4B
$131K ﹤0.01%
3,003
+1,429
+91% +$67.5K
CEVA icon
1862
CEVA Inc
CEVA
$1.08B
$131K ﹤0.01%
5,130
+3,138
+158% +$79K
RSPD icon
1863
Invesco S&P 500 Equal Weight Consumer Discretionary ETF
RSPD
$338M
$131K ﹤0.01%
2,847
-8,793
-76% -$378K
S icon
1864
SentinelOne
S
$7.34B
$131K ﹤0.01%
8,659
+7,384
+579% +$125K
ASO icon
1865
Academy Sports + Outdoors
ASO
$2.98B
$131K ﹤0.01%
2,419
-9,162
-79% -$526K
KSS icon
1866
Kohl's
KSS
$2.19B
$131K ﹤0.01%
5,667
-12,594
-69% -$272K
SWKS icon
1867
Skyworks Solutions
SWKS
$10.6B
$131K ﹤0.01%
1,180
-1,500
-56% -$158K
RLAY icon
1868
Relay Therapeutics
RLAY
$4.33B
$130K ﹤0.01%
10,362
+5,872
+131% +$73K
FLEX icon
1869
Flex
FLEX
$44.8B
$130K ﹤0.01%
6,248
+6,221
+23,041% +$111K
ENLT icon
1870
Enlight Renewable Energy
ENLT
$11.9B
$130K ﹤0.01%
+7,328
New +$130K
MACK
1871
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$130K ﹤0.01%
10,567
+9,332
+756% +$117K
AGIO icon
1872
Agios Pharmaceuticals
AGIO
$1.93B
$130K ﹤0.01%
4,582
+2,104
+85% +$52.4K
SPEM icon
1873
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.7B
$129K ﹤0.01%
3,763
+1,369
+57% +$46.8K
ARRY icon
1874
Array Technologies
ARRY
$855M
$129K ﹤0.01%
5,724
+3,845
+205% +$82.3K
APAM icon
1875
Artisan Partners
APAM
$3.02B
$129K ﹤0.01%
3,289
+1,600
+95% +$55.2K

Similar funds

Tower Research Capital (TRC)'s Q2 2023 Portfolio in Review

As of Q2 2023, Tower Research Capital (TRC) held 6,693 positions worth $3B, down 4.5% from $3.14B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) withdrew a net $317M in Q2 2023, closing 658 positions and reducing 2,422 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $22.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares MSCI USA Min Vol Factor ETF worth $5.5M.

  • Tower Research Capital (TRC)'s largest Q2 2023 buy was iShares MSCI USA Min Vol Factor ETF: 74,022 shares worth $5.5M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2023, an estimated $73.5M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2023 reduction was TSMC, cutting an estimated $335M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q2 2023, selling an estimated $22.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $3B portfolio in Q2 2023.
  • Tower Research Capital (TRC) opened 497 new positions and closed 658 in Q2 2023.
  • Tower Research Capital (TRC)'s portfolio value fell 4.5% quarter-over-quarter to $3B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2023, filed 14 Aug 2023.